ED50 and ED95 of Propofol Combined with Different Doses of Intravenous Lidocaine for First-Trimester Uterine Aspiration: A Prospective Dose-Finding Study Using Up-and-Down Sequential Allocation Method
DOI: https://doi.org/10.2147/DDDT.S382412
2022-09-28
Abstract:Jingwen Zhang, 1 Linglingli Kong, 2 Juan Ni 1 1 Department of Anesthesiology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, People's Republic of China; 2 Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, People's Republic of China Correspondence: Juan Ni, Department of Anesthesiology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, No. 20, Section 3, South of Renmin Road, Chengdu, Sichuan, 610041, People's Republic of China, Tel +86 18180609890, Fax +86 2885503752, Email Purpose: This study aimed to test the effect of different doses of intravenous lidocaine on the median effective dose (ED50) and 95% effective dose (ED95) of propofol-induction dose and identify the optimal dose. Patients and Methods: Patients undergoing first-trimester uterine aspiration were screened and randomly enrolled into the following groups: saline (L 0 ), 0.5 mg/kg lidocaine (L 0.5 ), 1.0 mg/kg lidocaine (L 1.0 ), and 1.5 mg/kg lidocaine (L 1.5 ). Anesthesia was induced with 1.0 μg/kg fentanyl. Prepared lidocaine or saline solution was injected later according to allocation, followed by propofol. The dose of propofol for each patient was determined using the up-and-down sequential study design. The primary end point was the ED50 and ED95 of the propofol-induction dose. The total propofol doses, awakening time, and adverse events were recorded. Results: The ED50 (95% confidence interval) of propofol was significantly lower in groups L 1.0 and L 1.5 than group L 0 (1.6 [1.5– 1.7] mg/kg and 1.8 [1.6– 1.9] mg/kg, versus 2.4 [2.3– 2.5] mg/kg, respectively; p < 0.001). There was no significant difference in ED50 between groups L 1.0 and L 1.5 ( p > 0.05). However, surprisingly, the ED50 was significantly higher in group L 0.5 than L 0 (2.8 [2.6– 3.0] mg/kg vs 2.4 [2.3– 2.5] mg/kg; p < 0.05). The total doses of propofol in groups L 1.0 and L 1.5 were lower than those in groups L 0 and L 0.5 ( p < 0.05). The systolic blood pressure (SBP) decline after anesthesia induction in group L 0.5 was greater than that in group L 0 ( p < 0.01). The incidence of respiratory depression in group L 0.5 was greater than that in groups L 0 and L 1.0 ( p < 0.05). Conclusion: In patients who underwent first-trimester uterine aspiration, intravenous lidocaine 1.0 mg/kg prior to propofol injection significantly reduced the ED50 of propofol induction dose without severe side effects, equivalent to the effect of 1.5 mg/kg dose. We recommend 1.0 mg/kg as the optimal dose. Keywords: lidocaine, propofol, uterine aspiration, median effective dose Propofol has been commonly used as an intravenous anesthetic to provide sedation in outpatient surgery, given its significantly shorter half-life than other agents. 1,2 However, sedation with propofol alone in a large dose is related to adverse respiratory and circulatory events. Higher doses of propofol can increase the risk of apnea, upper airway collapse, and hypotension; 3–7 whereas, lower doses can lead to inadequate sedation. Propofol administered in combination with other drugs may decrease the risk of respiratory and circulatory complications and provide safe and satisfactory sedation. Thus, an effective adjunct for attenuating the response to surgery and reducing the propofol requirement is needed. In recent years, both midazolam and dexmedetomidine have been used in outpatient surgery, but the half-life of midazolam is relatively long, and the induction of dexmedetomidine is slow and the preparation is cumbersome, so the application is limited. 8,9 Lidocaine is a widely used local anesthetic in clinical practice. 10 Previous studies have found that intravenous lidocaine could enhance the sedative effect of propofol-based anesthesia. 11–15 Other perioperative benefits of intravenous lidocaine include alleviated propofol injection pain, reduction of opioid requirement, accelerated recovery of gastrointestinal function after surgery, and decreased incidence of postoperative chronic pain. 16–19 Intravenous lidoc -Abstract Truncated-